COUGH is the #6 most commonly reported adverse reaction for INFANTS IBUPROFEN, manufactured by Aurohealth LLC. There are 3 FDA adverse event reports linking INFANTS IBUPROFEN to COUGH. This represents approximately 3.0% of all 101 adverse event reports for this drug.
Patients taking INFANTS IBUPROFEN who experience cough should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.
Reporting Frequency
COUGH3 of 101 reports
COUGH is a less commonly reported adverse event for INFANTS IBUPROFEN, but still significant enough to appear in the safety profile.
Other Side Effects of INFANTS IBUPROFEN
In addition to cough, the following adverse reactions have been reported for INFANTS IBUPROFEN:
COUGH has been reported as an adverse event in 3 FDA reports for INFANTS IBUPROFEN. This does not prove causation, but indicates an association observed in post-market surveillance data.
How common is COUGH with INFANTS IBUPROFEN?
COUGH accounts for approximately 3.0% of all adverse event reports for INFANTS IBUPROFEN, making it a notable side effect.
What should I do if I experience COUGH while taking INFANTS IBUPROFEN?
If you experience cough while taking INFANTS IBUPROFEN, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.
Disclaimer: This analysis is based on FDA adverse event reports and is for informational purposes only. Reports do not prove causation. Always consult your healthcare provider.